Advertisement
Screener

Verrica Pharmaceuticals Inc. (VRCA) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Verrica Pharmaceuticals Inc. Cash Flow Breakdown

Cash flow breakdown shows where Verrica Pharmaceuticals Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $17.63M went out.
  • Fiscal year ended 2025-12-31: from investing, $0.00 came in.
  • Fiscal year ended 2025-12-31: from financing, $1.45M came in.
  • Fiscal year ended 2025-12-31: change in cash, $16.18M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2025-12-31-$17.63M$0.00-$12.79M$0.00$14.23M*-$16.18M
2024-12-31-$60.93M-$19.00K$0.00$155.00K$37.57M*-$23.22M
2023-12-31-$38.58M-$362.00K$0.00$7.00K$74.21M*$35.27M
2022-12-31-$18.65M$54.04M-$43.75M$26.90M$18.52M
2021-12-31-$27.58M-$998.00K$0.00$28.12M$5.53M*$5.07M
2020-12-31-$30.21M-$3.58M$453.00K$34.78M*$1.45M
2019-12-31-$27.41M$25.95M$423.00K-$1.03M
2018-12-31-$17.87M-$79.89M$7.00K$99.37M*$1.61M
2017-12-31-$4.58M$12.72M*$8.14M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$9.28M*$0.00*$0.00*
2026-03-31-$9.16M$0.00$0.00-$9.28M
2025-12-31-$4.59M*$0.00*-$870.00K*$0.00*$14.51M*
2025-09-30$9.69M*$0.00*-$3.89M*$0.00*
2025-06-30-$10.04M*$0.00*-$4.07M*$0.00*
2025-03-31-$12.68M$0.00-$3.96M$0.00-$16.73M
2024-12-31-$16.06M*$8.00K*$0.00*$1.00K*$39.42M*
2024-09-30-$8.56M*-$16.00K*$0.00*$0.00*
2024-06-30-$16.36M*-$11.00K*$0.00*$150.00K*-$790.00K*
2024-03-31-$19.95M$0.00$0.00$4.00K-$665.00K*-$20.61M
2023-12-31-$14.51M*-$227.00K*$0.00*
2023-09-30-$14.81M*-$65.00K*$0.00*$44.04M*
2023-06-30-$4.67M*-$59.00K*$0.00*
2023-03-31-$4.59M-$11.00K$30.30M$25.68M
2022-12-31-$4.95M*$6.75M*$0.00*$0.00*
2022-09-30$1.82M*$2.07M*$26.90M*-$43.75M*
2022-06-30-$7.18M*$2.21M*$0.00*
2022-03-31-$8.34M$43.01M$0.00$34.66M
2021-12-31-$8.70M*$4.01M*$0.00*-$1.00K*
2021-09-30-$10.60M*$6.29M*$0.00*
2021-06-30$2.50M*-$22.14M*-$31.00K*
2021-03-31-$10.79M$10.84M$28.15M$5.21M*$33.41M
2020-12-31-$6.10M*-$858.00K*$446.00K*
2020-09-30-$7.61M*-$24.13M*$0.00*$0.00*
2020-06-30-$8.59M*$3.13M*$0.00*$0.00*
2020-03-31-$7.91M$18.27M$35.00M$7.00K$45.24M
2019-12-31-$8.21M*$6.65M*$204.00K*
2019-09-30-$7.23M*-$2.03M*$4.00K*
2019-06-30-$5.05M*$263.00K*$212.00K*-$4.58M*
2019-03-31-$6.92M$21.07M$3.00K$14.16M
2018-12-31-$6.90M*-$21.15M*-$28.04M*
2018-09-30-$5.14M*-$58.64M*-$1.06M*-$64.84M*
2018-06-30-$3.68M*-$94.00K*$79.44M*$75.66M*
2018-03-31-$2.15M-$17.00K$20.99M*$18.82M
2017-12-31-$1.85M*$10.11M*$8.27M*
2017-09-30-$1.07M*$965.00K*-$110.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
OS Therapies Inc (OSTX)United States$0.076B-2.17
iBio, Inc. (IBIO)United States$0.077B-2.94
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
Valion Bio, Inc. (VBIO)United States$0.077B
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Lifevantage Corp (LFVN)United States$0.078B15.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40